Reappraisal of Reported Genes for Sudden Arrhythmic Death

Abstract

Our results contest the clinical validity of all but 1 gene clinically tested and reported to be associated with BrS. These findings warrant a systematic, evidence-based evaluation for reported gene-disease associations before use in patient care.